Adams GP - Search Results

1

Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.

McCall AM, Adams GP, Amoroso AR, Nielsen UB, Zhang L, Horak E, Simmons H, Schier R, Marks JD, Weiner LM. McCall AM, et al. Among authors: adams gp. Mol Immunol. 1999 May;36(7):433-45. doi: 10.1016/s0161-5890(99)00057-7. Mol Immunol. 1999. PMID: 10449096

2

Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.

Adams GP, Tai MS, McCartney JE, Marks JD, Stafford WF 3rd, Houston LL, Huston JS, Weiner LM. Adams GP, et al. Clin Cancer Res. 2006 Mar 1;12(5):1599-605. doi: 10.1158/1078-0432.CCR-05-2217. Clin Cancer Res. 2006. PMID: 16533787

3

Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.

Adams GP, McCartney JE, Wolf EJ, Eisenberg J, Tai MS, Huston JS, Stafford WF 3rd, Bookman MA, Houston LL, Weiner LM. Adams GP, et al. Cancer Immunol Immunother. 1995 May;40(5):299-306. doi: 10.1007/BF01519629. Cancer Immunol Immunother. 1995. PMID: 7600561 Free PMC article.

4

A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.

Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I. Weiner LM, et al. Among authors: adams gp. Cancer Res. 1993 Jan 1;53(1):94-100. Cancer Res. 1993. PMID: 8093231

5

Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1.

Weiner LM, Holmes M, Richeson A, Godwin A, Adams GP, Hsieh-Ma ST, Ring DB, Alpaugh RK. Weiner LM, et al. Among authors: adams gp. J Immunol. 1993 Sep 1;151(5):2877-86. J Immunol. 1993. PMID: 8103070

6

Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.

Amoroso AR, Clark JI, Litwin S, Hsieh-Ma S, Shi T, Alpaugh RK, Adams GP, Wolf EJ, Ring DB, Weiner LM. Amoroso AR, et al. Among authors: adams gp. Cancer Res. 1996 Jan 1;56(1):113-20. Cancer Res. 1996. PMID: 8548750

7

Human neutrophil interactions of a bispecific monoclonal antibody targeting tumor and human Fc gamma RIII.

Weiner LM, Alpaugh RK, Amoroso AR, Adams GP, Ring DB, Barth MW. Weiner LM, et al. Among authors: adams gp. Cancer Immunol Immunother. 1996 Mar;42(3):141-50. doi: 10.1007/s002620050264. Cancer Immunol Immunother. 1996. PMID: 8640842 Free PMC article.

8

Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.

Adams GP, Schier R, Marshall K, Wolf EJ, McCall AM, Marks JD, Weiner LM. Adams GP, et al. Cancer Res. 1998 Feb 1;58(3):485-90. Cancer Res. 1998. PMID: 9458094

9

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.

Adams GP, Schier R, McCall AM, Crawford RS, Wolf EJ, Weiner LM, Marks JD. Adams GP, et al. Br J Cancer. 1998 May;77(9):1405-12. doi: 10.1038/bjc.1998.233. Br J Cancer. 1998. PMID: 9652755 Free PMC article.

10

Generating improved single-chain Fv molecules for tumor targeting.

Adams GP, Schier R. Adams GP, et al. J Immunol Methods. 1999 Dec 10;231(1-2):249-60. doi: 10.1016/s0022-1759(99)00161-1. J Immunol Methods. 1999. PMID: 10648942 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters